porphin

(redirected from Porphine)
Also found in: Encyclopedia.

porphin

 [por´fin]
the fundamental ring structure of four linked pyrrole nuclei around which porphyrins, hemin, cytochromes, and chlorophyll are built.

por·phin

, porphine (pōr'fin),
The unsubstituted cyclic tetrapyrrole nucleus that is the basis of the porphyrins.
See also: porphyrins. Compare: chlorin, phorbin, corrin.
Synonym(s): porphyrin

porphin

/por·phin/ (por´fin) the fundamental ring structure of four linked pyrrole nuclei around which porphyrins, hemin, cytochromes, and chlorophyll are built.

porphin

the fundamental ring structure of four linked pyrrole nuclei around which porphyrins, hemin, cytochromes and chlorophyll are built.
References in periodicals archive ?
patent 6,838,248 for an invention directed to "Compositions and Methods for Detecting Pre-Cancerous Conditions in Cell and Tissue Samples Using 5,10,15,20-Tetrakis (Carboxyphenyl) Porphine.
This technology, based on a compound called Tetrakis Carboxy Phenyl Porphine (TCPP), was developed at Los Alamos National Laboratories.
The new invention titled "Method for Detecting and Prognosing Pre-Cancerous Cells Using 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine," will be Biomoda's fourth U.
Biomoda's CyPath[R] labeling solution for the early detection of cancers is based on meso-tetra (4 carboxyphenyl) porphine or TCPP, a porphyrin compound that binds to cancer cells and fluoresces under specific frequencies of light.
Allowed by the Canadian Intellectual Property Office, Canadian patent application 2,429,526, "Compositions and Methods for Detecting Pre-Cancerous Conditions In Cell And Tissue Samples Using 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine," is similar to Biomoda's U.
Biomoda's CyPath[R] reagents for the early detection of cancers is based on meso-tetra (4 carboxyphenyl) porphine or TCPP, a porphyrin compound that binds to cancer cells and fluoresces under specific frequencies of light.
Issued by the Instituto Mexicano de la Propiedad Industrial (IMPI), Mexican patent #269352, "Compositions and Methods for Detecting Pre-Cancerous Conditions In Cell And Tissue Samples Using 5, 10, 15, 20-Tetrakis (Carboxyphenol) Porphine," is similar to Biomoda's U.
patent 7,670,799, entitled, "Composition and Method for Making 5, 10, 15, 20- Tetrakis (Carboxyphenyl) Porphine (TCPP)" directed to Biomoda's proprietary TCPP formulation for cancer and pre-cancer cell identification and analysis and a method of making the TCPP formulation.
Patent entitled "Method for Making 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine (TCPP) Solution and Composition Comprising TCPP," describes the new formulation of the Biomoda assay trademarked under the name CyPath[R].
Patent Office issued its Formal Notice of Allowance for a Patent developed by Biomoda researchers titled "Compositions and Methods for Detecting Precancerous Conditions in Cells and Tissue Samples using 5, 10, 15, 20 Tetrakis (Carboxyphenyl) Porphine.
5 percent reports that it has just received notification from the Canadian government of the granting of a patent for use of Tetrakis Porphine for the detecting and treating of lung cancer.